Finance

Beta
Lists
507789:BOM
Jagsonpal Pharmaceuticals Ltd
₹202.00
-0.22%
(-0.45) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 507789...
Open
₹205.20
High
₹206.00
Low
₹202.00
Mkt. cap
13.37B
Avg. vol.
7.68K
Volume
766.00
P/E ratio
32.01
52-wk high
₹301.80
52-wk low
₹154.90
EPS
₹6.31
Shares outstanding
26.20M
No. of employees
1K
Open
₹205.20
High
₹206.00
Low
₹202.00
Mkt. cap
13.37B
Avg. vol.
7.68K
Volume
766.00
P/E ratio
32.01
52-wk high
₹301.80
52-wk low
₹154.90
EPS
₹6.31
Shares outstanding
26.20M
No. of employees
1K
News stories
From sources across the web
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1.4K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websitejagsonpal.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
756.12M
744.65M
729.45M
642.03M
Cost of goods sold
269.27M
272.28M
264.53M
237.67M
Cost of revenue
269.27M
272.28M
264.53M
237.67M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
179.44M
165.46M
172.95M
155.45M
Operating expense
368.25M
331.89M
326.10M
315.96M
Total operating expenses
637.52M
604.17M
590.63M
553.63M
Operating income
118.60M
140.48M
138.82M
88.40M
Other non operating income
28.25M
30.27M
29.75M
31.68M
EBT including unusual items
144.31M
168.10M
145.21M
117.56M
EBT excluding unusual items
144.31M
168.10M
166.00M
117.56M
Income tax expense
36.36M
42.36M
35.70M
29.94M
Effective tax rate
25.20%
25.20%
24.59%
25.47%
Other operating expenses
150.31M
126.28M
126.45M
137.32M
Net income
107.95M
125.74M
109.51M
87.62M
Net profit margin
14.28%
16.89%
15.01%
13.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.54M
-2.65M
-2.57M
-2.52M
Net interest expenses
-2.54M
-2.65M
-2.57M
-2.52M
Depreciation and amortization charges
23.53M
23.86M
23.86M
23.19M
EBITDA
138.93M
164.18M
155.55M
112.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer